SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAB Dynamics Regulatory News (ABDP)

Share Price Information for AB Dynamics (ABDP)

Share Price is delayed by 15 minutes
Get Live Data
1,056.00    22.00 (2.13%)
Bid:
1,046.00
Ask:
1,054.00
Spread: 8.00 (0.765%)
Market Cap: £241.72m
ABDP Live PriceLast checked at - London Stock Exchange

Intraday AB Dynamics Share Chart

Director/PDMR Shareholding

22 Jun 2023 07:00

RNS Number : 5156D
AB Dynamics PLC
22 June 2023
 

22 June 2023

 

AB Dynamics plc

("AB Dynamics" or the "Company")

 

PDMR/PCA Shareholding

Issue of Equity

 

AB Dynamics plc (AIM: ABDP), the designer, manufacturer and supplier of advanced testing systems and measurement products to the global transport market, announces it has issued and allotted 33,334 ordinary shares of 1 penny each ("New Ordinary Shares"). The New Ordinary Shares are being issued to James Routh, Chief Executive Officer of the Company, pursuant to the exercise of options under certain share option schemes.

Accordingly, application has been made for the 33,334 New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective, and that dealings will commence in the New Ordinary Shares at 08.00 a.m. on 23 June 2023. The New Ordinary Shares will rank, pari passu, with the existing ordinary shares in the Company.

 

In conjunction with the option exercise and issue of New Ordinary Shares, Dr Routh has sold 27,101 New Ordinary Shares in order to meet the cost of the exercise and to satisfy personal taxation liabilities arising from the exercise. Following these transactions, Dr Routh's shareholding in the Company will increase by 6,233 shares to 25,433 shares, representing 0.11% per cent. of the Company's issued share capital.

 

Total voting rights

 

Following Admission, the Company's enlarged issued share capital will comprise 22,934,365 ordinary shares of 1 penny each. The Company does not hold any shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 and has been arranged for release by Felicity Jackson, on behalf of the Company Secretary.

 

Contact:

 

 

 

AB Dynamics plc

01225 860 200

Dr James Routh, Chief Executive Officer

Sarah Matthews-DeMers, Chief Financial Officer

 

 

Peel Hunt LLP

0207 418 8900

Mike Bell

 

Ed Allsopp

 

 

 

Tulchan Communications

0207 353 4200

James Macey White

 

Matt Low

 

 

 

The below notification made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

 1

Details of the relevant person / person closely associated

a)

Name

Dr James Routh

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer

a)

Name

AB Dynamics plc

b)

LEI

213800OFXZP4A7I47K43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii each type of transaction; (iii each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

ISIN: GB00B9GQVG73

b)

Nature of the transaction

1) Exercise of share options

2) Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1)

1230p

33,334

2)

2000p

27,101

d)

Aggregated information

- Aggregated volume

N/A

- Price

e)

Date of the transaction

20 June 2023

f)

Place of the transaction

1) Outside of a trading venue

2) London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUARAROVUNUUR
Date   Source Headline
3rd Apr 20247:00 amRNSAcquisition of Venshure and Notice of Results
28th Feb 202412:00 pmRNSResult of AGM
28th Feb 20247:00 amRNSHalf Year Pre-Close Trading Update
14th Feb 20247:00 amRNSShare Awards & Director/PDMR Dealings – AMENDMENT
13th Feb 20243:49 pmRNSShares Awards and Director/PDMR Dealings
6th Feb 20247:00 amRNSNotice of AGM & posting of Annual Report
24th Jan 20247:00 amRNSFinal Results
11th Dec 20237:00 amRNSNotice of Results
1st Nov 20237:00 amRNSBlock Listing Interim Review
27th Oct 202310:18 amRNSHolding(s) in Company
28th Sep 20237:00 amRNSPre-close Trading Update
26th Sep 20233:05 pmRNSHolding(s) in Company
22nd Jun 20237:00 amRNSDirector/PDMR Shareholding
14th Jun 20237:00 amRNSBlock Listing Six Monthly Return
25th Apr 20237:00 amRNSHalf-year Report
21st Mar 20237:00 amRNSTrading Update and Notice of Results
1st Mar 20239:07 amRNSTotal Voting Rights
11th Jan 20232:14 pmRNSResult of AGM
11th Jan 20237:00 amRNSAGM Statement
16th Dec 202211:15 amRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSNotice of AGM & posting of Annual Report
23rd Nov 20227:00 amRNSFinal Results
4th Nov 202211:55 amRNSHolding(s) in Company
1st Nov 20222:00 pmRNSBlock listing Interim Review
19th Oct 20229:54 amRNSHolding(s) in Company
23rd Sep 20222:18 pmRNSHolding(s) in Company
21st Sep 20227:00 amRNSPre-Close Trading Update & Acquisition of Ansible
6th Jul 20224:00 pmRNSHolding(s) in Company
28th Jun 20227:00 amRNSPDMR/PCA Shareholding
24th Jun 20227:00 amRNSHolding(s) in Company
13th May 20224:41 pmRNSSecond Price Monitoring Extn
13th May 20224:36 pmRNSPrice Monitoring Extension
13th May 20222:05 pmRNSSecond Price Monitoring Extn
13th May 20222:00 pmRNSPrice Monitoring Extension
29th Apr 20227:00 amRNSBlock Listing Six Monthly Return
27th Apr 20227:00 amRNSHalf-year Report
12th Apr 202210:25 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSTotal Voting Rights
23rd Mar 20227:00 amRNSTrading Update and Notice of Results
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20224:16 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSGrant of LTIP awards
9th Mar 202210:00 amRNSHolding(s) in Company
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
28th Jan 20225:30 pmRNSHolding(s) in Company
24th Jan 20224:41 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
12th Jan 20222:14 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.